<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>Operator_BCSC2019_S02_C17_p451_476_3aP</title>
		<link href="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="Operator_BCSC2019_S02_C17_p451_476_3aP" lang="en-US">
		<div id="_idContainer007" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span><span class="chapter-number">17</span></p>
			<p class="chapter-title">Principles of Radiology for the Comprehensive Ophthalmologist</p>
			<p class="video-list-mid"><img class="_idGenObjectAttribute-1" src="data:image/png;base64,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" alt="" />This chapter includes related activities, which can be accessed by scanning the QR codes provided in the text or &#173;going to <a href="http://www.aao.org/bcscactivity_section02"><span class="video-list-mid_Hyperlink">www.&#173;aao.&#173;org/&#173;bcscactivity_&#173;section02</span></a>.</p>
			<p class="h1 ParaOverride-1">Highlights</p>
			<div id="Chapt17_Top1">
			<p class="body-text--no-indent-">
			<ul>
				<li class="bullet-list-first ParaOverride-2">Computed tomography (CT) is the modality of choice when patients are being evaluated for acute hemorrhage, calcification, and diseases of the bone and orbit and in patients for whom magnetic resonance imaging (MRI) is contraindicated.</li>
				<li class="bullet-list-mid">MRI is the modality of choice for assessing the central ner&#173;vous system.</li>
				<li class="bullet-list-mid">Administration of contrast material improves the sensitivity and specificity of both CT and MRI in diagnosing a disease and should be requested &#173;unless &#173;there is a contraindication to contrast agents or it is not required.</li>
				<li class="bullet-list-mid">Vascular lesions can be evaluated by CT angiography and/or magnetic resonance angiography. The sensitivity of &#173;these studies varies by institution and should be compared with that of ce&#173;re&#173;bral angiography.</li>
				<li class="bullet-list-last ParaOverride-3">Ultrasonography uses high-&#173;frequency sound waves for evaluation of structures in the eye and orbit. The frequency of ultrasound is directly proportional to its resolution and inversely proportional to its depth of penetration.</li>
			</ul>
			</p>
			</div>
			<p class="h1 ParaOverride-1">Overview</p>
			<div id="Chapt17_Top2">
			<p class="body-text--no-indent-">Computed tomography (CT) and magnetic resonance imaging (MRI) are the most common imaging studies ordered by an ophthalmologist to evaluate the orbit, brain, and sometimes the eye. The ophthalmologist also relies on ultrasonography to provide biometrics, facilitate diagnosis, and evaluate the extent of ocular and orbital diseases. This chapter focuses on the basic princi&#173;ples of &#173;these imaging modalities, identification of normal anatomical structures, and recognition of the modality that is best suited to evaluate a certain clinical condition. For more specific indications for radiographic studies in par&#173;tic&#173;u&#173;lar diseases, consult BCSC volumes covering &#173;those entities. See also BCSC <span class="xref-local">Section&#160;5</span>, <span class="italic">Neuro-&#173;Ophthalmology.</span></p>
			</div>
			<p class="h1">Computed Tomography</p>
			<div id="Chapt17_Top3">
			<p class="body-text--no-indent-">Computed tomography technology is widely available and provides rapid acquisition of images. The scanners generate cross-&#173;sectional images of the body as an x-&#173;ray tube continuously rotates around the patient. Current-&#173;generation scanners can image body slices as thin as 0.5&#160;mm, which may be reformatted in multiple anatomical planes. In addition, the acquired sections can be reconstructed in varying thicknesses from the source data, depending on the study and anatomical region examined. Studies are conducted with or without intravenous contrast material enhancement depending on the clinical situation. Although contrast-&#173;enhanced studies can increase the sensitivity and specificity of CT scans in disease diagnosis, contrast is not always required. <span class="xref-table">&#173;Table&#160;17-1</span> pre&#173;sents some of the advantages and disadvantages of CT, as well as contraindications. CT scans are very useful for identifying acute intracranial/orbital hemorrhage and osseous abnormalities, where the ease of CT and rapidity in obtaining images make it the method of choice for evaluating trauma involving the face and orbit.</p>
			<p class="body-text">Generally, for evaluation of orbital conditions, thin-&#173;section (ie, high-&#173;resolution) studies are critical to delineate the small anatomical structures of the orbit (<span class="xref-figure">Fig 17-1</span>):</p>
			<ul>
				<li class="bullet-list-first">lacrimal gland</li>
				<li class="bullet-list-mid">extraocular muscles</li>
				<li class="bullet-list-mid">globe</li>
				<li class="bullet-list-last">paranasal sinuses around the orbit</li>
			</ul>
			<p class="body-text--no-indent-">Axial scans are always performed during orbital studies. However, coronal reformations, which provide optimal evaluation of the orbital roof and floor, should also be a standard part of &#173;these examinations. Sagittal reformations may be added to help further characterize and localize lesions.</p>
			<p class="body-text">Further, CT is an excellent modality for evaluating the vascular system. CT angiography (CTA) combines intravenous contrast enhancement with high-&#173;resolution imaging to produce high-&#173;quality, noninvasive scans of arterial and venous pathologies. Three-&#173;dimensional reformations that mimic catheter angiography are routinely produced and can detect ce&#173;re&#173;bral aneurysms mea&#173;sur&#173;ing 3–5&#160;mm with high sensitivity and specificity. Additional series acquired at &#173;later times (CT venography) can be used to evaluate the ce&#173;re&#173;bral venous system, especially in suspected cases of venous thrombosis or obstruction.</p>
			<p class="body-text">When additional diagnostic information is needed, CT scans can be combined with nuclear medicine imaging, as in single-&#173;photo emission computed tomography (SPECT) and positron emission tomography (PET-&#173;CT). &#173;These modalities use radiolabeled molecules to help evaluate metabolic activity in a wide range of diseases. SPECT is commonly used to evaluate myo&#173;car&#173;dial perfusion and brain function, whereas PET-&#173;CT scans are typically used to diagnose and stage tumors, as well as to diagnose degenerative diseases of the brain. In ophthalmology, PET-&#173;CT has been used to assess ocular adnexal lymphoma and cortical blindness. In addition, PET-&#173;CT scans of the body are utilized in evaluation of patients with sarcoidosis and for metastatic screening of patients with uveal melanoma.</p>
			<p class="reference--journal--first">Betts AM, O’Brien WT, Davies BW, Youssef OH. A systematic approach to CT evaluation of orbital trauma. <span class="reference--journal-_italic">Emerg Radiol</span>. 2014;21(5):511–531.</p>
			<p class="reference--journal--last">Yang ZL, Ni QQ, Schoepf UJ, et&#160;al. Small intracranial aneurysms: diagnostic accuracy of <br />CT angiography. <span class="reference--journal-_italic">Radiology.</span> 2017;285(3):941–952.</p>
			<p class="h2 ParaOverride-4">Disadvantages</p>
			<p class="body-text--no-indent-">Although CT is a transformational noninvasive technology for evaluating orbital and central ner&#173;vous system diseases, ophthalmologists should be aware of the limitations of this imaging modality and safety concerns. CT scans employ ionizing radiation, a potential concern especially in pediatric cases and pregnant patients. In general, CT scans expose the patient to higher doses of radiation than conventional x-&#173;ray studies do. CT scans of the brain are typically oriented to avoid imaging of the globe, which is a more radiosensitive organ. In the International System of Units, millisievert (mSv) is the unit used to determine the amount of tissue damage expected from the absorbed dose of ionizing radiation. Millisievert is technically dif&#173;fer&#173;ent from milligray (mGy), which refers to the total dose of ionizing radiation delivered to a tissue during a par&#173;tic&#173;u&#173;lar scan sequence. The National Science Foundation has estimated that 10 mSv of radiation may cause an additional case of cancer in 1/1000 patients. However, the impact of a single (or even serial) CT scan(s) of the brain in relation to the risk of cancer development is typically outweighed by the clinical need for diagnostic information; nonetheless, ordering clinicians should be aware of this safety consideration when ordering a CT scan, particularly in &#173;children.</p>
			<p class="body-text">While CT scans are very useful in studying bony structures, visibility of the posterior fossa may be reduced &#173;because of streak artifact from the skull base. Further, in evaluation of the central ner&#173;vous system, CT scans provide lower spatial resolution than does MRI, although the intravenous administration of iodinated contrast material improves the soft-&#173;tissue imaging capabilities of CT.</p>
			<p class="body-text">Iodinated contrast agents pose another potential safety concern for patients undergoing CT, mostly related to allergic reactions and potential nephrotoxicity in &#173;those with under&#173;lying renal insufficiency. Allergic reactions have ranged from 1% to 12%, depending on the type of contrast material used, with symptoms ranging from relatively mild (eg, pruritus, nausea, and vomiting) to severe (eg, anaphylaxis). The rate of severe allergic reactions has been reduced to less than 0.1% with the use of newer low osmolar contrast agents. Nephrotoxicity has been reported in 2%–7% of patients receiving contrast media, with higher rates in &#173;those with preexisting kidney disease and/or diabetes mellitus. The American College of Radiology (ACR) currently recommends limiting intravenous contrast agent administration in patients with an estimated glomerular filtration rate less than 30 mL/min/1.73 m<span class="superscript _idGenCharOverride-1">2</span>, and considering alternative imaging methods (eg, MRI) or hydrating before the examination. &#173;Because recommendations for the use of contrast agents vary by institution, consultation with a diagnostic radiologist is advised before ordering contrast-&#173;enhanced CT examinations in at-&#173;risk patients.</p>
			<p class="reference--journal--first">American College of Radiology, ACR Committee on Drugs and Contrast Media. ACR Manual on Contrast Media. Version 10.3; 2018. <a href="http://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf"><span class="reference--journal-_Hyperlink">www.&#173;acr.&#173;org/&#173;-&#173;/&#173;media/&#173;ACR/&#173;Files/&#173;Clinical-&#173;Resources/&#173;Contrast_&#173;Media.&#173;pdf</span></a>. Accessed February&#160;25, 2019.</p>
			<p class="reference--journal--last ParaOverride-5">Meinel FG, De Cecco CN, Schoepf UJ, Katzberg&#160;R. Contrast-&#173;induced acute kidney injury: definition, epidemiology, and outcome. <span class="reference--journal-_italic">Biomed Res Int.</span> 2014;2014:859328.</p>
			</div>
			<p class="h1 ParaOverride-6">Magnetic Resonance Imaging</p>
			<div id="Chapt17_Top4">
			<p class="body-text--no-indent-">&#173;Because of its superior contrast resolution, MRI is the imaging modality of choice for evaluation of the central ner&#173;vous system (see &#173;Table&#160;17-1). In addition, the technology does not use ionizing radiation, which is a relative advantage over CT. Instead, MRI uses a strong magnetic field that &#173;causes hydrogen atoms found in &#173;water and fat to align themselves with the field. Once the atoms are aligned, protons within a selected imaging section/volume are exposed to a series of radiofrequency (RF) and/or magnetic gradient pulses and become excited. As the protons relax again to a steady state, they emit radio waves, which are detected by a receiver coil in the MRI system. The time it takes for the signal to reach the MRI machine following the applied RF (or gradient) pulse is known as the <span class="italic">echo time (TE),</span> which varies by type of tissue. The time between RF pulses is known as the <span class="italic">repetition time (TR).</span> <br />The TE and TR can be adjusted to modify the contrast between images and thus enhance visualization of dif&#173;fer&#173;ent tissues.</p>
			<p class="body-text">The energy given off by the rotating protons is expressed by 2 aspects: the longitudinal relaxation constant, or T1, and the transverse relaxation constant, or T2. T1-&#173;weighted images (T1WIs), which are generated with shorter TEs and TRs, are typically used for contrast-&#173;enhanced studies. In a T1WI, &#173;water appears dark (hypointense) and fat appears bright (hyperintense). Melanin shows an intrinsically elevated T1 signal, which can be helpful in providing a diagnosis in patients with melanoma. Sometimes, however, fat suppression is required in T1WIs to improve contrast enhancement and characterization of tissues, such as the optic nerve and other orbital structures. In comparison, T2-&#173;weighted images (T2WIs) use a longer TE to depict differences in &#173;water content, thus revealing inflammatory, ischemic, and neoplastic-&#173;related edematous changes. On T2WIs, vitreous, cerebrospinal, and other fluids are bright.</p>
			<p class="body-text">On both T1WIs and T2WIs, gray &#173;matter is hypointense compared with white &#173;matter (<span class="xref-table">&#173;Table&#160;17-2</span>, <span class="xref-figure">Fig 17-2</span>). In fluid-&#173;attenuated inversion recovery (FLAIR) images, the fluid signal is suppressed on T2WIs, facilitating visualization of signal abnormalities associated with changes in the periventricular white &#173;matter (eg, as in multiple sclerosis).</p>
			<p class="body-text">Gadolinium-&#173;based contrast medium is administered intravenously and used to enhance T1WIs, especially for assessment of inflammatory and neoplastic lesions. Gadolinium may also be administered during high spatial and temporal resolution MRI sequences of large&#173; and medium-&#173;sized vessels (ie, MR angiography [MRA]), when dynamic contrast enhancement can be assessed more practically than with CTA. The decision to use MRA versus CTA for evaluation of intracranial and orbital blood vessels is often complex and varies depending on the patient and clinical question being asked; consultation with a neuroradiologist may be required in complex cases.</p>
			<p class="body-text"><span class="italic">Diffusion-&#173;weighted imaging (DWI)</span> is another form of MRI that is relevant to the ophthalmologist, as this sequence is the most sensitive for the detection of acute ischemic changes (eg, cerebrovascular accident). DWI can detect changes within minutes compared with potentially hours with other MRI methods. A quantitative metric of DWI sequences, the apparent diffusion coefficient, can be used to further characterize edema as cytotoxic versus vasogenic (eg, posterior reversible encephalopathy syndrome) (<span class="xref-table">&#173;Table&#160;17-3</span>).</p>
			<p class="h2">Disadvantages</p>
			<p class="body-text--no-indent-">Adverse effects are occasionally associated with the gadolinium chelates used for contrast-&#173;enhanced imaging in MRI, though at a lower frequency than with iodinated contrast agents in CT. Common symptoms are sweating, pruritus, and rash. Although gadolinium agents do not adversely affect renal function at the doses administered for clinical imaging, certain gadolinium chelates may be restricted in patients with severe end-&#173;stage renal disease &#173;because of the risk of nephrogenic systemic fibrosis, a rare and potentially fatal multiorgan fibrosing disorder. In addition, gadolinium has been shown to collect in certain neurologic structures &#173;after repeated administration; however, no clinical features have been attributed to this deposition. Recommendations for the use of gadolinium-&#173;based contrast agents vary by institution; thus, the ophthalmologist is advised to consult with a diagnostic radiologist before ordering such studies in at-&#173;risk patients.</p>
			<p class="body-text">&#173;Because MRI uses strong magnetic fields to generate pictures, patients with metallic foreign bodies or implants should also be carefully screened before undergoing imaging. Ophthalmologists may be consulted to assess patients for foreign bodies on the ocular surface, within the eye, and/or in the orbit. The incidence of damage from undetected ocular foreign bodies during MRI is low, restricted to a few case reports; however, it is not zero. This is an impor&#173;tant consideration when counseling patients before their scans. Patients are also screened at the imaging center before MRI.</p>
			<p class="body-text">The following list highlights general and ophthalmic concerns in patients scheduled to undergo MRI. The reader is also directed to the ACR safety guidelines (see reference list) for further details.</p>
			<p class="body-text">Considerations when ordering an MRI:</p>
			<ul>
				<li class="bullet-list-first">Metal in the body, including metallic intraocular or orbital foreign bodies<p class="bullet-list-sub-bullet-list ParaOverride-7"><span class="CharOverride-1">n</span>&#9;Screening radiography or CT may be helpful in detecting intraocular and orbital foreign bodies.</p><p class="bullet-list-sub-bullet-list ParaOverride-7"><span class="CharOverride-1">n</span>&#9;Consultation with a diagnostic radiologist is advised regarding the safety of some metals (eg, MRI-&#173;compatible aneurysm clips).</p><p class="bullet-list-sub-bullet-list ParaOverride-7"><span class="CharOverride-1">n</span>&#9;Gold weight and titanium mesh orbital floor implants have shown no movement when placed in a magnetic field. Some clinicians prefer to wait for fibrosis to secure the implant before obtaining an MRI.</p></li>
				<li class="bullet-list-mid">Cardiac pacemaker or defibrillator<p class="bullet-list-sub-bullet-list ParaOverride-7"><span class="CharOverride-1">n</span>&#9;Consultation with a diagnostic radiologist regarding all implantable devices is advised.</p></li>
				<li class="bullet-list-last">Allergy to gadolinium-&#173;based contrast media</li>
			</ul>
			<p class="body-text">Activities 17-1 and 17-2 demonstrate normal structures identified on axial and coronal orbital imaging, respectively, with CT and MRI.</p>
			<p class="activity-first-verso ParaOverride-8"><span class="QR-code-activity-number">&#9;ACTIVITY 17-1</span> Axial imaging of the normal orbit with computed <br />tomography and magnetic resonance imaging.</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer002" class="_idGenObjectStyleOverride-1">
					<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
						<img class="_idGenObjectAttribute-2" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAC0AAAA8CAYAAADykDOkAAAACXBIWXMAABcRAAAXEQHKJvM/AAAEpUlEQVRoQ+2abUhbVxiA/bvfhY39Gh1Mh9a0WBJXN6sREpwRjbjEWU222CHTgvTHlI7R2ozQMdQwQp1msI+iW0eh020UDbjF+TFlxqqZVSpYxSB+hcn2ww82eXfOqcclN7n33NzcGzLICw/kfr3v43tvDufcmAYAaYJ88uZjuP4qxM3wnQ+YtUTCPOH/Je26tAAO/Z9wI/+IKSQGu/aA5PN+eZ0lxYL/YFtFgCkihSG3gyXFInLnbYsf2owBaM3/hykgBYfuL5Lf+8UNlpx46Y9KgszCcjDgcrLk2NKf2qbBVfNIsQ5zufV6kNT7OfaO/7fxYdEes5AS/NDWxZKMlHbXTxBiHCXshrNgupAVwfA7aua18UuzkvJgzc+C9PT0CPos55nXJlzaUXoWbBfPgPpMBpHs7OyEsbExqKmpIdsGdSY57r0ssuN4aP3qqgdGv25myUqWNl8I77DX6wUcTU1NYfvvXsph5grjvuMOSzZuaZfLBYODg7C9vU2kZ2dnyXZtbW3ySk9MTEC0aGlpSUmnpFPSKemUdEpaREIlpfGc+vuP3fDwwdss2eSRljTLu9d6l9B6UdSKJTmk6YbIlUtySX/z/nfQ894DuFlwKIc0XtngVQyXJ1dfeZrL+cYTUm/y/hWWJJfInYzVuFhpPpzGc09zybIal0m6q6sLqqurIygoKCDXtehV4HtXA77b1771+XyvcVleXn454dJ84XQ6Be8ABa2A7kHM0p9f+QU635o7wV54IId0T08PlJWV8ULvhM1m8ywuLqooa2trLwJTmgvnralUaVb09fVF7bzVav0JBKRfQJxeX18/HQgETvj7s4YR8k0/xpx/7kAJaY/HA0VFRSfk5eUR6aqqqnHssbW19TxEkd7DF2s0mrC/dGVlJT3knDSz2fyrEtLcwKv8UA9cF6j07u7uqWP2EKBWq8NOnpub04Scc6qysvK3REiPjo6SBubk5ERKs77NfCgtTQPXYUpnZmYKkpGRkXzS+BERCnRxSpoVUaX39/efwahUqj18MDs7G9Bn2NzcjJrk8PAQ0PlwdHQU9bjcEVWafqDSlI2NDeFsCQpB6WAw+OzOzs5zaMj7A5+Um5tLBnjK0tKScHaFQlCagsbGYLQhDs0DhHIrFqKk8QRldXX1JYpWq13BFxUWFoJOp4OFhQWhGrKHKGkuer3+cWjHZ2Zm+PIrEpKk0bOcNT8/f57KFxcXQ0VFBfj9fr46ssTU1BSpg+rGLk1Bc97Z0I4rPU4LTpiAR5IL6qx6cnJSW1JS8iiR0kaj8SGui+42Wt7HKE1J9NSUtQgQBZVGk3NoaGiQ/dmenp4meU0mk/zSFPqTnFwxMDAQ9izLIj0yMlLc399voc+2xWKB5uZmvFiINJAQVLq8vHwG1xkfH9dBvNIU3IHQjuBicgSVrq+v/xF4ajPl+BgaGirv7e1tNBgMv8shjX88tdvtUFdXp5w0BSeXQ5r7CiEh0o2NjdDe3g5oPAUpQaVLS0v9brf7GmqCCZSWpuDiUoJKS3stFiOomLWjo+MWmpMsHheF7u7umKH/xZAQaQouFtpxqSRa+iYqOhwvOA+r1r+5EXjdkTR2kwAAAABJRU5ErkJggg==" alt="" />
					</div>
				</div>
			</div>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer003" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/qrcode_BCSC2019_S02_activity17-01.png" alt="" />
				</div>
			</div>
			<p class="activity-first-verso"><span class="qr-code-source_italic">Developed by Vikram&#160;S. Brar, MD. Figures reproduced with permission from Dutton JJ.</span> <br /><span class="figure-source-emphasis">Atlas of Clinical and Surgical Orbital Anatomy. </span><br /><span class="qr-code-source_italic">2nd&#160;ed. Elsevier/Saunders; 2011: Figs 11-1 to 11-6.</span></p>
			<p class="activity-first-verso">Access all Section&#160;2 activities at <a href="http://www.aao.org/bcscactivity_section02">www.&#173;aao.&#173;org/&#173;bcscactivity_&#173;section02</a>.</p>
			<p class="activity-first-verso ParaOverride-9"><span class="QR-code-activity-number">&#9;ACTIVITY 17-2</span> Coronal imaging of the normal orbit with computed tomography and magnetic resonance imaging.</p>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer005" class="_idGenObjectStyleOverride-1">
					<div id="_idContainer004" class="_idGenObjectStyleOverride-1">
						<img class="_idGenObjectAttribute-2" src="data:image/png;base64,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" alt="" />
					</div>
				</div>
			</div>
			<div class="_idGenObjectLayout-1">
				<div id="_idContainer006" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/qrcode_BCSC2019_S02_activity17-02.png" alt="" />
				</div>
			</div>
			<p class="activity-first-verso"><span class="qr-code-source_italic">Developed by Vikram&#160;S. Brar, MD. Figures reproduced with permission from Dutton JJ.</span> <br /><span class="figure-source-emphasis">Atlas of Clinical and Surgical Orbital Anatomy. <br /></span><span class="qr-code-source_italic">2nd&#160;ed. Elsevier/Saunders; 2011: Figs 11-7 to 11-12.</span></p>
			<p class="reference--journal--first ParaOverride-10">Expert Panel on MR Safety; Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document on MR safe practices: 2013. <span class="reference--journal-_italic">J Magn Reson Imaging.</span> 2013;37(3):501–530.</p>
			<p class="reference--journal--mid ParaOverride-11">Lawrence DA, Lipman AT, Gupta SK, Nacey NC. Undetected intraocular metallic foreign body causing hyphema in a patient undergoing MRI: a rare occurrence demonstrat-<br />ing the limitations of pre-&#173;MRI safety screening. <span class="reference--journal-_italic">Magn Reson Imaging.</span> 2015;33(3):<br />358–361.</p>
			<p class="reference--journal--mid">Marra S, Leonetti JP, Konior RJ, Raslan&#160;W. Effect of magnetic resonance imaging on implantable eyelid weights. <span class="reference--journal-_italic">Ann Otol Rhinol Laryngol.</span> 1995;104(6):448–452.</p>
			<p class="reference--journal--mid">Modjtahedi BS, Rong A, Bobinski M, McGahan J, Morse&#160;L. Imaging characteristics of intraocular foreign bodies: a comparative study of plain film X-&#173;ray, computed tomography, ultrasound, and magnetic resonance imaging. <span class="reference--journal-_italic">Ret&#173;i&#173;na.</span> 2015;35(1):95–104.</p>
			<p class="reference--journal--mid">Seidenwurm DJ, McDonnell CH III, Raghavan N, Breslau&#160;J. Cost utility analy&#173;sis of <br />radiographic screening for an orbital foreign body before MR imaging. <span class="reference--journal-_italic">Am J Neuroradiol.</span> 2000;21(2):426–433.</p>
			<p class="reference--journal--mid">&#173;Sullivan PK, Smith JF, Rozzelle AA. Cranio-&#173;orbital reconstruction: safety and image quality <br />of metallic implants on CT and MRI scanning. <span class="reference--journal-_italic">Plast Reconstr Surg.</span> 1994;94(5):589–596.</p>
			<p class="reference--journal--last ParaOverride-5">Williamson MR, Espinosa MC, Boutin RD, Orrison WW Jr, Hart BC, Kelsey CA. Metallic foreign bodies in the orbits of patients undergoing MR imaging: prevalence and value of radiography and CT before MR.&#160;<span class="reference--journal-_italic">AJR</span> <span class="reference--journal-_italic">Am J Roentgenol.</span> 1994;162(4):981–983.</p>
			</div>
			<p class="h1 ParaOverride-12">Ultrasonography</p>
			<div id="Chapt17_Top5">
			<p class="body-text--no-indent-"><span class="italic">Ultrasound</span> refers to sound waves with frequencies above the audible range. Ultrasonography uses echoes, much like light-&#173;based optical coherence tomography uses reflections, to image and differentiate tissues. During ultrasonography, electrical energy is converted into sound waves by means of a piezoelectric crystal. The resultant waves are emitted by the ultrasound probe, which is placed as close as pos&#173;si&#173;ble to the tissue being studied. When the sound waves encounter tissues, their speed changes depending on the density of the surface/interface, and some of the waves bounce back to the probe; on the basis of their amplitude, frequency, and travel time, &#173;these echoes are then converted into a signal. For example, during ultrasonography, a sound wave traversing the cornea encounters the aqueous of the anterior chamber and then the lens–&#173;iris diaphragm. As the tissue density changes at the posterior cornea and then again at the lens–&#173;iris diaphragm, signals are generated. The distance between the 2 signal spikes is then used to determine the anterior chamber depth.</p>
			<p class="body-text">The frequency of the ultrasound determines the depth of penetration and the resolution. &#173;These 2 variables are inversely related. High-frequency ultrasound, which provides greater detail, is used to evaluate smaller objects such as the eye. Low-frequency ultrasound provides less resolution but can penetrate deeper. For example, it is useful in obstetrics to traverse through the abdominal wall and uterus to image a fetus.</p>
			<p class="body-text">Ophthalmic ultrasonography utilizes high-&#173;frequency sound waves (8–80&#160;MHz) for safe, effective, noninvasive imaging of the anterior and posterior segments of the eye and orbit using equipment routinely found in most practices. Indications for ophthalmic ultrasonography include biometry and evaluation of the following structures and conditions:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-13">intraocular structures with media opacities</li>
				<li class="bullet-list-mid">posterior sclera</li>
				<li class="bullet-list-mid">extraocular muscles and the surrounding orbit</li>
				<li class="bullet-list-last ParaOverride-14">intraocular tumors</li>
			</ul>
			<p class="body-text--no-indent-">Three main ultrasound devices are used to evaluate the eye: the A-&#173;scan probe, the B-&#173;scan probe, and the ultrasound biomicroscopy (UBM) probe (<span class="xref-figure">Fig 17-3</span>).</p>
			<p class="reference--journal--single ParaOverride-15">Singh AD, Hayden BC. <span class="reference--journal-_italic">Ophthalmic Ultrasonography.</span> Philadelphia: Elsevier/Saunders; 2012.</p>
			<p class="h2">A-&#173;Scan</p>
			<p class="body-text--no-indent-">Biometry of the eye with an A-&#173;scan probe (eg, for mea&#173;sur&#173;ing axial length) uses frequencies between 8 and 12&#160;MHz. &#173;After a topical anesthetic agent is applied, the probe makes direct contact with the cornea, or it can be applied via immersion. The latter eliminates the possibility of altering the mea&#173;sure&#173;ment with compression of the cornea.</p>
			<p class="body-text">When operating at 8&#160;MHz, the A-&#173;scan probe can also enable demonstration of intralesional characteristics within the eye and orbit, known as<span class="italic"> internal reflectivity.</span> Reflectivity within a lesion may be low, medium, or high depending on the relative percentage of the internal spike compared with that of the initial spike of the lesion (<span class="xref-table">&#173;Table&#160;17-4</span>). The reflectivity within a tissue is inversely proportional to its homogeneity. Less-&#173;organized tissue, as in a vascular lesion (ie, a choroidal hemangioma), &#173;will demonstrate high internal reflectivity compared with homogenous tissue (ie, a choroidal melanoma).</p>
			<p class="h2">B-&#173;Scan</p>
			<p class="body-text--no-indent-">B-&#173;scan ultrasonography commonly uses 10&#160;MHz, with axial resolution of 100 µm, to provide 2-&#173;dimensional images of the eye and orbit. Combining data from 2 orthogonal scans at a given point yields 3-&#173;dimensional information: shape, location, and extent. Three types of B-&#173;scans—&#173;axial, transverse, and longitudinal—&#173;are obtained depending on the position of the probe on the eye and the orientation of the linear white marker on its surface (<span class="xref-figure">Fig 17-</span><span class="xref-figure">4</span>). &#173;These scans are best performed with direct contact on an anesthetized ocular surface, facilitated by a coupling agent such as methylcellulose. This improves image resolution and allows the examiner to monitor the position of the patient’s eyes. The probe marker indicates the direction of the scan and corresponds to the top of the 2-&#173;dimensional B-&#173;scan image.</p>
			<p class="h3">Axial scans</p>
			<p class="body-text--no-indent-">Axial scans are performed by placing the probe directly on the cornea with the patient looking straight ahead and the probe marker oriented vertically at 12 &#173;o’clock or horizontally with the probe marker oriented nasally (<span class="xref-figure">Fig 17-5</span>). This allows visualization of the posterior pole and the optic nerve. The posterior sclera and under&#173;lying Tenon space can also be examined, as in cases of posterior scleritis. Attenuation of the signal by the cornea and lens limits the resolution of &#173;these scans.</p>
			<p class="h3">Transverse scans</p>
			<p class="body-text--no-indent-">During B-&#173;scan ultrasonography, transverse scans cover the greatest area of the posterior segment of the eye. The probe is placed on the sclera, avoiding image degradation from the anterior segment, and is oriented parallel to the limbus, providing a circumferential scan of the opposing ret&#173;ina (ie, when imaging the nasal quadrant, the probe is placed on the temporal sclera with the patient adducting his or her eye; <span class="xref-figure">Fig 17-6</span>). The farther the probe traverses posteriorly from the limbus, the more the anterior part of the eye is imaged (ie, with the patient looking just nasal to midline, the probe is touching the edge of the limbus, and the back of the 2-&#173;dimensional image is posterior to the equator). As the patient looks farther nasally, the probe slides posteriorly on the surface of the globe and the scan is directed more anteriorly (<span class="xref-figure">Fig 17-7</span>). This maximizes visualization of that quadrant.</p>
			<p class="body-text">When the posterior segment cannot be visualized, 4 transverse scans (ie, superior, inferior, nasal, and temporal) in addition to the axial scan are typically performed as part of the screening B-&#173;scan. The nasal and temporal scans are known as the <span class="italic">lateral transverse scans</span> (see Fig 17-6). By convention, when the superior or inferior eye is imaged, the probe marker is oriented nasally. In all other positions, the probe marker is oriented superiorly. <span class="xref-figure">Figure&#160;17-8</span> demonstrates the appropriate positioning of the probe and the orientation of the marker for the 4 primary transverse scans.</p>
			<p class="h3">Longitudinal scans</p>
			<p class="body-text--no-indent-">Similar to transverse scans, longitudinal scans are performed with the probe placed on the sclera, with the marker oriented perpendicular to the limbus. &#173;These scans are performed when a lesion is identified on a screening B-&#173;scan and describe the anterior-&#173;posterior extent. The optic nerve should be visualized below the center on longitudinal scans (<span class="xref-figure">Fig 17-</span><span class="xref-figure">9</span>). Longitudinal scans can also be used to visualize the macula (<span class="xref-figure">Fig 17-10</span>).</p>
			<p class="h3">Dynamic B-&#173;scan</p>
			<p class="body-text--no-indent-">B-&#173;scan ultrasonography is not a static pro&#173;cess. Already, we have discussed the anterior-to-posterior excursion of the ultrasound probe to increase the area imaged during transverse scans. In addition, the patient can be asked to look up and down during lateral transverse scans and right and left during superior/inferior transverse scans to study movement of the vitreous/posterior hyaloid face and a detached ret&#173;ina. Furthermore, the gain of the scan can be adjusted to enhance visualization of par&#173;tic&#173;u&#173;lar structures (<span class="xref-table">&#173;Table&#160;17-5</span>).</p>
			<p class="body-text"><span class="xref-figure">Figures&#160;17-11, 17-12, and 17-13</span> highlight the differential diagnoses requiring ophthalmic ultrasonography and their diagnostic features.</p>
			<p class="h2">Ultrasound Biomicroscopy</p>
			<p class="body-text--no-indent-">Ultrasound biomicroscopy (UBM) utilizes the highest frequency available in ophthalmic ultrasonography, usually 50&#160;MHz, with axial resolution of 37 µm, and is used to evaluate the anterior segment of the eye. It requires topical anesthesia and a fluid reservoir, which is placed in direct contact with the cornea and/or anterior sclera depending on which structures need to be evaluated. Two types of scans are obtained with UBM depending on the orientation of the probe. <span class="italic">Axial</span> UBM scans are generated by placing the probe on the cornea positioned horizontally (<span class="xref-figure">Fig 17-14</span>). This allows visualization of the cornea, the anterior chamber, the iris with the pupil in the center of the iris plane, and the lens. <span class="italic">Radial</span> UBM scans are generated by centering the probe at the limbus, with the marker oriented perpendicular to the limbus. The anterior chamber &#173;angle, iris, and ciliary body can be evaluated with this scan (<span class="xref-figure">Fig 17-15</span>).</p>
			<p class="reference--journal--single ParaOverride-5">Fledelius HC. Ultrasound in ophthalmology. <span class="reference--journal-_italic">Ultrasound Med Biol.</span> 1997;23(3):365–375.</p>
			</div>
			<p class="h1 ParaOverride-16">Ordering Imaging Studies</p>
			<div id="Chapt17_Top6">
			<p class="body-text--no-indent-">Requesting the correct study is imperative for arriving at the correct diagnosis. Imaging &#173;orders should include clinical information regarding the patient, the location or perceived location of the pathology to be studied, use of a contrast agent, and urgency. The more detail provided with the order, the higher the likelihood of obtaining the desired information. Communication with the diagnostic radiologist can facilitate this pro&#173;cess and increase the yield. <span class="xref-table">&#173;Table&#160;17-6</span> provides recommendations for ordering a study. <span class="xref-table">&#173;Tables&#160;17-7</span> and <span class="xref-table">17-8</span> cover specific disease entities, recommended imaging modality, and use of contrast material for common neuro-&#173;ophthalmic and orbital conditions, respectively.</p>
			<p class="reference--journal--first">Kruger JM, Lessell S, Cestari DM. Neuro-&#173;imaging: a review for the general ophthalmologist. <span class="reference--journal-_italic">Semin Ophthalmol.</span> 2012;27(5-6):192–196.</p>
			<p class="reference--journal--mid">Lee AG, Brazis PW, Garrity JA, White&#160;M. Imaging for neuro-&#173;ophthalmic and orbital disease. <span class="reference--journal-_italic">Am J Ophthalmol.</span> 2004;138(5):852–862.</p>
			<p class="reference--journal--mid">Lee AG, Johnson MC, Policeni BA, Smoker WR. Imaging for neuro-&#173;ophthalmic and orbital disease: a review. <span class="reference--journal-_italic">Clin Exp Ophthalmol.</span> 2009;37(1):30–53.</p>
			<p class="reference--journal--mid">Simha A, Irodi A, David&#160;S. Magnetic resonance imaging for the ophthalmologist: a primer. <span class="reference--journal-_italic">Indian J Ophthalmol.</span> 2012;60(4):301–310.</p>
		</div>
		</div>
		<div id="_idContainer008" class="Basic-Text-Frame">
			<table id="table001" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-5" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">Table&#160;17-1</span> Comparison of Magnetic Resonance Imaging and Computed Tomography</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Advantages</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Disadvantages</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Contraindications</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Better able to distinguish white &#173;matter from gray &#173;matter</p>
							<p class="table-body">Better visualization of posterior fossa pathology</p>
							<p class="table-body">Better visualization of soft tissue</p>
							<p class="table-body">Better resolution of optic nerve and orbital apex</p>
							<p class="table-body">Ability to establish evolution of intraparenchymal hemorrhage</p>
							<p class="table-body">No ionizing radiation</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Contrast dye reactions and systemic nephrogenic fibrosis</p>
							<p class="table-body">Greater cost</p>
							<p class="table-body">Susceptibility artifacts from metal <br />(eg, braces) or air–&#173;tissue interfaces</p>
							<p class="table-body">Longer acquisition time</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Cochlear implants</p>
							<p class="table-body">Ferromagnetic implants/foreign bodies</p>
							<p class="table-body">Metallic cardiac valves</p>
							<p class="table-body">Non–&#173;MRI-&#173;compatible intracranial aneurysm clips</p>
							<p class="table-body">Pacemakers</p>
							<p class="table-body">Pregnancy (ie, gadolinium is Category C for pregnant patients)</p>
							<p class="table-body">Renal insufficiency</p>
							<p class="table-body">Other considerations: claustrophobia/patient too large for the bore</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">CT</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Assessment of bony abnormalities</p>
							<p class="table-body">Assessment of orbital and hyperacute intracranial hemorrhage</p>
							<p class="table-body">Detection of calcification in lesions</p>
							<p class="table-body">Evaluation of globe and orbital trauma (includes high-&#173;resolution bone algorithms)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Exposure to ionizing radiation (CT head radiation dose <span class="table-body_symbol">=</span> 1.5 mGy<span class="table-body_superscript _idGenCharOverride-1">a</span>)</p>
							<p class="table-body">Reaction to iodine-&#173;based contrast agents</p>
							<p class="table-body">Lack of direct sagittal imaging</p>
							<p class="table-body">&#173;Limited resolution in the posterior fossa</p>
							<p class="table-body">Poor resolution of the orbital apex</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Renal insufficiency (ie, if estimated GFR is <span class="table-body_symbol">&lt;</span>30&#160;mL/min/1.73&#160;m<span class="table-body_superscript _idGenCharOverride-1">2</span>)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRA/MRV</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Less invasive than catheter angiography</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">&#173;Limited resolution (in aneurysms <span class="table-body_symbol">≤</span>3&#160;mm)</p>
							<p class="table-body">Pos&#173;si&#173;ble overestimation of carotid stenosis or venous sinus stenosis</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Same as for MRI</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">CTA/CTV</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Less invasive than catheter angiography</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Artifacts from superimposed bone and adjacent vessels, especially where aneurysms lie within or close to bone</p>
							<p class="table-body">&#173;Limited resolution (in aneurysms <span class="table-body_symbol">≤</span>3&#160;mm)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Same as for CT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-12">
						<td class="Basic-Table CellOverride-6" colspan="7">
							<p class="table-footnote">CT <span class="table-body_symbol">=</span> computed tomography; CTA <span class="table-body_symbol">=</span> computed tomography angiography; CTV <span class="table-body_symbol">=</span> computed tomography venography; GFR <span class="table-body_symbol">=</span> glomerular filtration rate; MRA <span class="table-body_symbol">=</span> magnetic resonance angiography; MRI <span class="table-body_symbol">=</span> magnetic resonance imaging; MRV <span class="table-body_symbol">=</span> magnetic resonance venography.</p>
							<p class="table-source-note ParaOverride-17"><span class="table-source-note_superscript _idGenCharOverride-1">a</span> <span class="table-source-note_italic">Milligray (mGy)</span> refers to the total dose of ionizing radiation delivered to a tissue and is not the same as millisievert (mSv), the SI unit that takes into account the type of imaging study and the biological effects of the radiation dose. The biological effect of the total mGy delivered &#173;varies depending on the tissue being examined. Some tissues (eg, gonads, eye) are more radiosensitive than &#173;others (eg, the skin), and the differing effects of a similar mGy dose on &#173;these organ systems are taken into account by reporting radiation doses in the unit mSv.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer011">
				<div id="_idContainer009" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-1</span> Computed tomography (CT) scans. <span class="figure-caption_bold">A,</span> Axial orbital view of a healthy subject. Note the orbital and intracanalicular portions of the optic nerve. <span class="figure-caption_bold">B,</span> Coronal orbital view of a healthy subject. <span class="figure-source-note">(Courtesy of Rod Foroozan, MD.)</span></p>
				</div>
				<div id="_idContainer010" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_01.png" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer012" class="Basic-Text-Frame">
			<table id="table002" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-16" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1" colspan="9">
							<p class="table-title"><span class="table-number">&#173;Table&#160;17-2</span> Signal Characteristics of Normal Ocular Structures in Dif&#173;fer&#173;ent Imaging Sequences</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-7">
							<p class="table-column-head">Ocular Structure</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-column-head">Signal Intensity on <br />T1-&#173;Weighted Images<span class="table-column-head_superscript _idGenCharOverride-1">a</span></p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Signal Intensity on <br />T2-&#173;Weighted Images<span class="table-column-head_superscript _idGenCharOverride-1">a</span></p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Enhancement on Postcontrast Images<span class="table-column-head_superscript _idGenCharOverride-1">a</span></p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-column-head">Additional Comments</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Sclera, choroid, ret&#173;ina (seen as a single coat)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Hyperintense <br />(bright/white)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Hypointense <br />(dark/black)</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">The 3 coats cannot be distinguished separately on routine imaging</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Aqueous</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hypointense <br />(dark/black)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hyperintense <br />(bright/white)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Lens</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hyperintense <br />(bright/white)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Low (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Typically has a biconvex appearance</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Vitreous</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hypointense <br />(dark/black)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hyperintense <br />(bright/white)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Extraocular muscles</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Intermediate (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Intermediate (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Enhances brightly</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Orbital fat</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hyperintense <br />(bright/white)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Intermediate (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Typically has a homogeneous appearance</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Optic nerve</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Isointense to ce&#173;re&#173;bral white &#173;matter (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Isointense to ce&#173;re&#173;bral white &#173;matter (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Does not typically enhance; it can be compared with the extraocular muscles</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Optic nerve sheath with ce&#173;re&#173;bral spinal fluid around the optic nerve</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hypointense <br />(dark/black)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hyperintense <br />(bright/white)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Lacrimal gland</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Isointense with gray &#173;matter (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Isointense with gray &#173;matter (gray)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Enhances brightly</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Bone</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Signal void (dark)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Signal void (dark)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Better studied with computed tomography</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-22">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Ce&#173;re&#173;bral spinal fluid</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Hypointense <br />(dark/black)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Hyperintense <br />(bright/white)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">None</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-9" colspan="9">
							<p class="table-source-note"><span class="table-source-note_superscript _idGenCharOverride-1">a</span> Signal intensity (hypointense/hyperintense) is described in comparison with the reference tissue. Intracranially, the reference tissue is the gray &#173;matter of the brain; extracranially, it is the skeletal muscle.</p>
							<p class="table-source-note">Modified with permission from Simha A, Irodi A, David&#160;S. Magnetic resonance imaging for the ophthalmologist: a primer. <span class="table-source-note_italic">Indian J Ophthalmol.</span> 2012;60(4):308.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer015">
				<div id="_idContainer013" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_02.png" alt="" />
				</div>
				<div id="_idContainer014" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-2</span> Brain and orbital magnetic resonance (MR) images showing the anatomy of visual and orbital structures from the chiasm to the anterior orbit. (The left-globe abnormality is <br />not pertinent to the figure’s objective.) <span class="figure-caption_bold">A,</span> T1-&#173;weighted axial image. <span class="figure-caption_bold">B–&#173;D,</span> T1-&#173;weighted coronal images. <span class="figure-caption_bold">E,</span> T2-&#173;weighted coronal image with fat saturation. <span class="figure-caption_bold">F,</span> T1-&#173;weighted coronal image. ACF <span class="figure-caption_symbol">=</span> anterior cranial fossa; Ant segment <span class="figure-caption_symbol">=</span> anterior segment; ICA <span class="figure-caption_symbol">=</span> internal carotid <br />artery; IO <span class="figure-caption_symbol">=</span> inferior oblique muscle; IR <span class="figure-caption_symbol">=</span> inferior rectus muscle; LR <span class="figure-caption_symbol">=</span> lateral rectus muscle; Lev P <span class="figure-caption_symbol">=</span> <br />levator palpebrae superioris muscle; MCF <span class="figure-caption_symbol">=</span> &#173;middle cranial fossa; MR&#160;<span class="figure-caption_symbol">=</span> medial rectus muscle; Olf fossa <span class="figure-caption_symbol">=</span> olfactory fossa; SO <span class="figure-caption_symbol">=</span> superior oblique muscle; Sph sinus <span class="figure-caption_symbol">=</span> sphenoid sinus; Sph wing <span class="figure-caption_symbol">=</span> sphenoid wing; SR <span class="figure-caption_symbol">=</span> superior rectus muscle; Temp lobe <span class="figure-caption_symbol">=</span> temporal lobe; Vit <span class="figure-caption_symbol">=</span> vitreous. <span class="figure-source-note">(Courtesy of M. Tariq Bhatti, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer016" class="_idGenObjectStyleOverride-1">
			</div>
		</div>
		<div id="_idContainer017" class="Basic-Text-Frame">
			<table id="table003" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-24" />
					<col class="_idGenTableRowColumn-25" />
					<col class="_idGenTableRowColumn-26" />
					<col class="_idGenTableRowColumn-25" />
					<col class="_idGenTableRowColumn-27" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table _1-BCSC-table-title" colspan="5">
							<p class="table-title"><span class="table-number">Table 17-3</span> Edema: DWI and ADC</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table _3-BCSC-table-column-head">
							<p class="table-column-head">Type of Edema</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head" />
						<td class="Basic-Table _3-BCSC-table-column-head">
							<p class="table-column-head">DWI Signal</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head" />
						<td class="Basic-Table _3-BCSC-table-column-head">
							<p class="table-column-head">ADC Signal</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-28">
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-10">
							<p class="table-body">Cytotoxic</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-10" />
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-10">
							<p class="table-body">Bright (high or restricted diffusion)<span class="table-body_superscript CharOverride-2">a</span></p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-10" />
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-10">
							<p class="table-body">Dark (low)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-29">
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-11">
							<p class="table-body">Vasogenic</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-11" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-11">
							<p class="table-body">Dark (low)</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-11" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-11">
							<p class="table-body">Normal (sometimes bright)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-30">
						<td class="Basic-Table _8-BCSC-table-note" colspan="5">
							<p class="table-footnote">ADC = apparent diffusion coefficient; DWI = diffusion-weighted imaging.</p>
							<p class="table-footnote ParaOverride-18"><span class="table-source-note_superscript _idGenCharOverride-1">a</span> Bright signal on DWI represents restricted diffusion or decreased water movement.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer018" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure&#160;17-3</span> Ophthalmic ultrasound probes. <span class="figure-caption_bold">A,</span> A-&#173;scan probe. <span class="figure-caption_bold">B,</span> B-&#173;scan probe. <span class="figure-caption_bold">C,</span> Ultrasound biomicroscopy (UBM) probe. <span class="figure-source-note">(Courtesy of Vikram&#160;S. Brar, MD.)</span></p>
		</div>
		<div id="_idContainer019" class="Basic-Text-Frame">
			<table id="table004" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-31" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-33" />
					<col class="_idGenTableRowColumn-34" />
					<col class="_idGenTableRowColumn-35" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1" colspan="4">
							<p class="table-title"><span class="table-number">&#173;Table&#160;17-4</span> A-&#173;Scan: Quantification of Reflectivity</p>
						</td>
						<td class="Basic-Table CellOverride-1" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-12" />
						<td class="Basic-Table CellOverride-12">
							<p class="table-column-head ParaOverride-19">Grade</p>
						</td>
						<td class="Basic-Table CellOverride-12" />
						<td class="Basic-Table CellOverride-12">
							<p class="table-column-head">A-&#173;Scan Spike Height, %</p>
						</td>
						<td class="Basic-Table CellOverride-12" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-28">
						<td class="Basic-Table CellOverride-13" />
						<td class="Basic-Table CellOverride-13">
							<p class="table-body ParaOverride-20">Low</p>
						</td>
						<td class="Basic-Table CellOverride-13" />
						<td class="Basic-Table CellOverride-13">
							<p class="table-body">0–33</p>
						</td>
						<td class="Basic-Table CellOverride-13" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-14" />
						<td class="Basic-Table CellOverride-14">
							<p class="table-body ParaOverride-20">Medium</p>
						</td>
						<td class="Basic-Table CellOverride-14" />
						<td class="Basic-Table CellOverride-14">
							<p class="table-body">34–66</p>
						</td>
						<td class="Basic-Table CellOverride-14" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-36">
						<td class="Basic-Table CellOverride-15" />
						<td class="Basic-Table CellOverride-15">
							<p class="table-body ParaOverride-20">High</p>
						</td>
						<td class="Basic-Table CellOverride-15" />
						<td class="Basic-Table CellOverride-15">
							<p class="table-body">67–100</p>
						</td>
						<td class="Basic-Table CellOverride-15" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-30">
						<td class="Basic-Table CellOverride-6" colspan="4">
							<p class="table-source-note">Reproduced with permission from Singh AD, Hayden BC. <span class="table-source-note_italic">Ophthalmic Ultrasonography.</span> Philadelphia: Elsevier/Saunders; 2012:20.</p>
						</td>
						<td class="Basic-Table CellOverride-6" />
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer020" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_03.png" alt="" />
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer023">
				<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_04.png" alt="" />
				</div>
				<div id="_idContainer022" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-4</span> Three primary scans used in B-&#173;scan ultrasonography. <span class="figure-caption_bold">A,</span> Transverse scan. <span class="figure-caption_bold">B,</span> Longitudinal scan. <span class="figure-caption_bold">C,</span> Axial scan. <span class="figure-source-note">(Illustration by Cyndie&#160;C.H. Wooley.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer026">
				<div id="_idContainer024" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_05.png" alt="" />
				</div>
				<div id="_idContainer025" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-5</span> Vertical axial B-&#173;scan ultrasonography of the left eye. <span class="figure-caption_bold">A,</span> The probe is placed directly on the cornea and oriented vertically. <span class="figure-caption_bold">B,</span> Corresponding fundus photo&#173;graph. The white line indicates the corresponding section of the fundus being imaged at the posterior aspect of the scan. <span class="figure-caption_bold">C,</span> Two-&#173;dimensional B-&#173;scan image. Based on the orientation of the probe, the top of the scan is the superior ret&#173;ina. Le <span class="figure-caption_symbol">=</span> lens; ON <span class="figure-caption_symbol">=</span> optic nerve; Or <span class="figure-caption_symbol">=</span> orbit; Re <span class="figure-caption_symbol">=</span> ret&#173;i&#173;na; Sc <span class="figure-caption_symbol">=</span> sclera; Vi <span class="figure-caption_symbol">=</span> vitreous. <span class="figure-source-note">(Courtesy of Vikram&#160;S. Brar, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer029">
				<div id="_idContainer027" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-6</span> Lateral transverse B-&#173;scan ultrasonography of the left eye. <span class="figure-caption_bold">A,</span> The probe is on the temporal sclera (left eye) with the patient looking to his right and the marker oriented up. <br /><span class="figure-caption_bold">B,</span> Corresponding fundus photo&#173;graph is shown. The white line indicates the corresponding section of the fundus being imaged at the posterior aspect of the scan. <span class="figure-caption_bold">C,</span> The back of the scan is the nasal ret&#173;ina, and the top is the superior ret&#173;ina. MR <span class="figure-caption_symbol">=</span> medial rectus muscle; Or <span class="figure-caption_symbol">=</span> orbit; Re <span class="figure-caption_symbol">=</span> ret&#173;ina, Sc <span class="figure-caption_symbol">=</span> sclera; Vi <span class="figure-caption_symbol">=</span> vitreous. <span class="figure-source-note">(Courtesy of Vikram&#160;S. Brar, MD.)</span></p>
				</div>
				<div id="_idContainer028" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_06.png" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer030" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure&#160;17-7</span> When transverse scans are per -<br />formed, anterior - to - posterior excursion of the B-&#173;scan probe maximizes visualization of the desired quadrant. <span class="figure-source-note">(Illustration by Cyndie&#160;C.H. Wooley.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer031" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_07.png" alt="" />
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer034">
				<div id="_idContainer032" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_08.png" alt="" />
				</div>
				<div id="_idContainer033" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-8</span> Model of the left eye, showing positioning of the probe and orientation of the probe marker in the 4 primary transverse scans performed in a screening B-&#173;scan. The probe marker is oriented up for lateral transverse scans (<span class="figure-caption_bold">A,</span> temporal; <span class="figure-caption_bold">B,</span> nasal) and nasally for <br />inferior <span class="figure-caption_bold">(C)</span> and superior <span class="figure-caption_bold">(D)</span> scans. <span class="figure-source-note">(Courtesy of Vikram&#160;S. Brar, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer037">
				<div id="_idContainer035" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-9</span> Superior longitudinal B-&#173;scan ultrasonography of the left eye. <span class="figure-caption_bold">A,</span> The probe is placed directly on the sclera (left eye) with the patient looking up and the marker oriented vertically, perpendicular to the limbus. <span class="figure-caption_bold">B,</span> Corresponding fundus photo&#173;graph is shown. The white line indicates the corresponding section of the fundus being imaged at the posterior aspect of the scan. &#173;These scans demonstrate the anterior-&#173;posterior extent of a lesion. <span class="figure-caption_bold">C,</span> In the 2-&#173;dimensional B-&#173;scan image, the back of the scan represents the superior fundus. Note the positioning of the optic nerve, which is found &#173;toward the bottom of longitudinal scans. ON <span class="figure-caption_symbol">=</span> optic nerve; Or <span class="figure-caption_symbol">=</span> orbit; SR <span class="figure-caption_symbol">=</span> superior rectus muscle. <span class="figure-source-note">(Courtesy of Vikram&#160;S. Brar, MD.)</span></p>
				</div>
				<div id="_idContainer036" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_09.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer040">
				<div id="_idContainer038" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-10</span> Longitudinal B-&#173;scan ultrasonography demonstrating the macula in the left eye. <br /><span class="figure-caption_bold">A,</span> The patient is asked to abduct his or her eye. The probe is placed directly on the nasal sclera with the marker oriented perpendicular to the limbus. <span class="figure-caption_bold">B,</span> Corresponding fundus photo&#173;graph is shown. The white line indicates the corresponding section of the fundus being imaged at the posterior aspect of the scan. <span class="figure-caption_bold">C,</span> In this 2-&#173;dimensional image, the top of the scan demonstrates the lateral rectus muscle; the optic nerve is &#173;toward the bottom of longitudinal scans. The intervening ret&#173;ina includes the macula. LR <span class="figure-caption_symbol">=</span> lateral rectus muscle; Ma <span class="figure-caption_symbol">=</span> macula; ON <span class="figure-caption_symbol">=</span> optic nerve. <span class="figure-source-note">(Courtesy of Vikram&#160;S. Brar, MD.)</span></p>
				</div>
				<div id="_idContainer039" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_10.png" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer041" class="Basic-Text-Frame">
			<table id="table005" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-37" />
					<col class="_idGenTableRowColumn-38" />
					<col class="_idGenTableRowColumn-39" />
					<col class="_idGenTableRowColumn-38" />
					<col class="_idGenTableRowColumn-1" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table&#160;17-5</span> B-&#173;Scan: Tissue-&#173;Specific Gain Setting</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Tissue</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Decibel Value, dB</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Gain Setting</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-28">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Vitreous</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">75–100</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">High</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Ret&#173;i&#173;na/choroid</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">55–75</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Medium</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-36">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Sclera/orbit/calcification</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">35–55</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Low</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-30">
						<td class="Basic-Table CellOverride-6" colspan="5">
							<p class="table-source-note">Modified with permission from Singh AD, Hayden BC. <span class="table-source-note_italic">Ophthalmic Ultrasonography.</span> Philadelphia: &#173;Elsevier/Saunders; 2012:18.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer042" class="Basic-Text-Frame">
			<table id="table006" class="No-Table-Style">
				<colgroup>
					<col class="_idGenTableRowColumn-40" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-41" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-42">
						<td class="No-Table-Style TB CellOverride-16">
							<p class="table-column-head"><span class="CharOverride-3">Diagnosis</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-16" />
						<td class="No-Table-Style TB CellOverride-16">
							<p class="table-column-head"><span class="CharOverride-3">Ultrasonographic Findings</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-43">
						<td class="No-Table-Style TB CellOverride-17">
							<p class="table-body"><span class="CharOverride-3">Myositis Graves orbitopathy</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-17">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">1</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-18">
							<p class="table-body"><span class="CharOverride-3">Thickened extraocular muscles</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-44">
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body"><span class="CharOverride-3">Periorbital space-&#173;occupying lesions</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">2</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-20">
							<p class="table-body"><span class="CharOverride-3">Change in the relief of the orbital wall, sound propagation into perinasal sinuses</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-10">
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body"><span class="CharOverride-3">Orbital neoplasm</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">3</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-20">
							<p class="table-body"><span class="CharOverride-3">Directly evident (it may be difficult to demonstrate a small cavernous hemangioma &#173;because of its high acoustic reflectivity)</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-10">
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body"><span class="CharOverride-3">Inflammatory orbital pseudotumor</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">4</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-20">
							<p class="table-body"><span class="CharOverride-3">Widening of normal orbital structures, low acoustic reflectivity, Tenon space may be demonstrated</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body"><span class="CharOverride-3">Disc edema</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">5</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-20">
							<p class="table-body"><span class="CharOverride-3">Widened dural dia&#173;meter of the optic nerve</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-7">
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body"><span class="CharOverride-3">Axial hyperopia</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">6</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-20">
							<p class="table-body"><span class="CharOverride-3">Axial length below 22&#160;mm, ocular walls concentrically thickened</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-45">
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body"><span class="CharOverride-3">Ocular hypotony</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">7</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-20">
							<p class="table-body"><span class="CharOverride-3">Ocular walls concentrically thickened</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-44">
						<td class="No-Table-Style TB CellOverride-19">
							<p class="table-body"><span class="CharOverride-3">Macular degeneration</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-19" />
						<td class="No-Table-Style TB CellOverride-20">
							<p class="table-body"><span class="CharOverride-3">Thickening of the ocular walls in the area of the macula, high acoustic reflectivity</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-46">
						<td class="No-Table-Style TB CellOverride-21">
							<p class="table-body"><span class="CharOverride-3">Scleritis</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-21">
							<p class="table-body ParaOverride-21"><span class="CharOverride-3">8</span></p>
						</td>
						<td class="No-Table-Style TB CellOverride-22">
							<p class="table-body"><span class="CharOverride-3">Circumscribed widening of the ocular walls, Tenon space apparent</span></p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer043" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure&#160;17-11</span> Schematic of ultrasonographic findings. The dotted line separates the top half of the eye from the bottom half, which is shorter (demonstrating hyperopia) and where different disease processes are depicted. <span class="figure-caption_italic">Inset:</span> Differential diagnosis for choroidal folds. <span class="figure-source-note">(Adapted with permission from Schachat AP, Wilkinson CP, Hinton DR, Sadda SR, Wiedemann P, eds.</span> <span class="figure-source-emphasis">Ryan’s </span><span class="figure-source-emphasis"><br />Ret&#173;ina. </span><span class="figure-source-note">6th&#160;ed.</span> <span class="figure-source-note">Philadelphia: Elsevier; 2017:321, &#173;Table&#160;11.3 and Fig 11.85.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer047">
				<div id="_idContainer044" class="Basic-Text-Frame">
					<table id="table007" class="No-Table-Style">
						<colgroup>
							<col class="_idGenTableRowColumn-47" />
							<col class="_idGenTableRowColumn-48" />
							<col class="_idGenTableRowColumn-49" />
						</colgroup>
						<tbody>
							<tr class="No-Table-Style _idGenTableRowColumn-42">
								<td class="No-Table-Style TB CellOverride-23">
									<p class="table-column-head"><span class="CharOverride-3">Diagnosis</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-23" />
								<td class="No-Table-Style TB CellOverride-23">
									<p class="table-column-head"><span class="CharOverride-3">Ultrasonographic Findings</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-42">
								<td class="No-Table-Style TB CellOverride-24" colspan="3">
									<p class="table-head"><span class="CharOverride-3">Normal axial length for the patient’s age</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-44">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Retinoblastoma</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">1</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Widening of the ocular walls, extremely high acoustic reflectivity, shadowing effect, aty&#173;pi&#173;cal findings pos&#173;si&#173;ble</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-44">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Congenital cataract</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">2</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Increased reflectivity from the posterior lens surface, vitreous space empty, ocular walls normal</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-20">
								<td class="No-Table-Style TB CellOverride-25" colspan="3">
									<p class="table-head"><span class="CharOverride-3">Shortened axial length</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-44">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Retinopathy of prematurity</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">3</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">In stages IV and V, beginning or complete traction detachment (normal findings in stages I–&#173;III)</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-10">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">PFV</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">4</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Dense strand of tissue between optic nerve head and posterior lens pole; formes frustes may occur (posterior <br />or anterior PFV)</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-44">
								<td class="No-Table-Style TB CellOverride-20" colspan="2">
									<p class="table-body"><span class="CharOverride-3">Ret&#173;i&#173;nal <br />anomalies</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Membranes in the vitreous, aty&#173;pi&#173;cal detachment, which in part appears solid (no typical echogram)</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-44">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Fundus coloboma</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">5</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Directly demonstrable protrusion of ocular wall, sometimes with orbital cyst (microphthalmos with cyst)</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-50">
								<td class="No-Table-Style TB CellOverride-22">
									<p class="table-body"><span class="CharOverride-3">Coats disease</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-22">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">6</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-22">
									<p class="table-body"><span class="CharOverride-3">Floating crystals in the vitreous and subret&#173;i&#173;nal space (fast-&#173;flickering spikes on A-&#173;mode)</span></p>
								</td>
							</tr>
						</tbody>
					</table>
				</div>
				<div id="_idContainer045" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-12</span> Schematic of ultrasonographic findings. <span class="figure-caption_italic">Inset:</span> Differential diagnosis for leukocoria. PFV = persistent fetal vasculature. <span class="figure-source-note">(Adapted with permission from Schachat AP, Wilkinson CP, Hinton DR, Sadda SR, Wiedemann P, eds.</span> <span class="figure-source-emphasis">Ryan’s Ret&#173;i&#173;na.</span> <span class="figure-source-note">6th&#160;ed. Philadelphia: Elsevier; 2017:322, &#173;Table&#160;11.4 and Fig 11.86.)</span></p>
				</div>
				<div id="_idContainer046" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_12.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer048" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_11.png" alt="" />
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer052">
				<div id="_idContainer049" class="Basic-Text-Frame">
					<table id="table008" class="No-Table-Style">
						<colgroup>
							<col class="_idGenTableRowColumn-51" />
							<col class="_idGenTableRowColumn-48" />
							<col class="_idGenTableRowColumn-52" />
						</colgroup>
						<tbody>
							<tr class="No-Table-Style _idGenTableRowColumn-42">
								<td class="No-Table-Style TB CellOverride-26">
									<p class="table-column-head"><span class="CharOverride-3">Diagnosis</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-26" />
								<td class="No-Table-Style TB CellOverride-26">
									<p class="table-column-head"><span class="CharOverride-3">Ultrasonographic Findings</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-23">
								<td class="No-Table-Style TB CellOverride-27">
									<p class="table-body"><span class="CharOverride-3">Symptomatic posterior vitreous detachment</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-27">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">1</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-27">
									<p class="table-body"><span class="CharOverride-3">Thickened detached posterior hyaloid membrane, occasionally early <br />ret&#173;i&#173;nal detachment</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-10">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Recently formed ret&#173;i&#173;nal break with torn vessel</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">2</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Blood-&#173;covered vitreous strands converge &#173;toward the ret&#173;i&#173;nal break; occasionally a high-&#173;floating operculum may be detected</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-44">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Proliferative retinopathy</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">3</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Strands or membranes extending from the optic nerve head or the posterior pole, high acoustic reflectivity</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-53">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Terson syndrome </span><span class="CharOverride-3">(vitreous </span><span class="CharOverride-3">hemorrhage &#173;after subchoroidal bleeding</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">4</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Vitreous opacities in front of the optic nerve head or &#173;behind the detached vitreous</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-10">
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Disciform macular degeneration</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">5</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-20">
									<p class="table-body"><span class="CharOverride-3">Widening of the ocular walls in the macular area, high acoustic reflectivity, vitreous strands extending from the macula</span></p>
								</td>
							</tr>
							<tr class="No-Table-Style _idGenTableRowColumn-54">
								<td class="No-Table-Style TB CellOverride-22">
									<p class="table-body"><span class="CharOverride-3">Choroidal melanoma</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-22">
									<p class="table-body ParaOverride-21"><span class="CharOverride-3">6</span></p>
								</td>
								<td class="No-Table-Style TB CellOverride-22">
									<p class="table-body"><span class="CharOverride-3">Biconvex thickening of the ocular wall, low acoustic reflectivity, sometimes mushroom-&#173;shaped; accompanying ret&#173;i&#173;nal detachment distant from the tumor</span></p>
								</td>
							</tr>
						</tbody>
					</table>
				</div>
				<div id="_idContainer050" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-13</span> Schematic of ultrasonographic findings. <span class="figure-caption_italic">Inset:</span> Differential diagnosis for vitreous hemorrhage. <span class="figure-source-note">(Adapted with permission from Schachat AP, Wilkinson CP, Hinton DR, Sadda SR, Wiedemann P, eds.</span> <span class="figure-source-emphasis">Ryan’s Ret&#173;i&#173;na.</span> <span class="figure-source-note">6th&#160;ed. Philadelphia: Elsevier; 2017:322, &#173;Table&#160;11.5 and Fig 11.87.)</span></p>
				</div>
				<div id="_idContainer051" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_13.png" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer053" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure&#160;17-14</span> Ultrasound biomicroscopy (UBM). <span class="figure-caption_bold">A,</span> &#173;After the eye is anesthetized, the probe is placed directly on the cornea, in this case, oriented horizontally. <span class="figure-caption_bold">B,</span> Axial scan of the anterior segment. AC <span class="figure-caption_symbol">=</span> anterior chamber; CB <span class="figure-caption_symbol">=</span> ciliary body; Co <span class="figure-caption_symbol">=</span> cornea; Ir <span class="figure-caption_symbol">=</span> iris; Le <span class="figure-caption_symbol">=</span> lens anterior capsule; PC <span class="figure-caption_symbol">=</span> posterior chamber; Sc <span class="figure-caption_symbol">=</span> sclera. <span class="figure-source-note">(Cour</span><span class="figure-source-note">tesy of Vikram&#160;S. Brar, MD.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer054" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_14.png" alt="" />
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer057">
				<div id="_idContainer055" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure&#160;17-15</span> Radial UBM. <span class="figure-caption_bold">A,</span> Slit-&#173;lamp photo&#173;graph. The white line demonstrates the location and orientation of the probe. <span class="figure-caption_bold">B,</span> Radial scan demonstrates the structures. AC <span class="figure-caption_symbol">=</span> anterior chamber; Ag <span class="figure-caption_symbol">=</span> &#173;angle; An <span class="figure-caption_symbol">=</span> anterior hyaloid face; CB <span class="figure-caption_symbol">=</span> ciliary body; Ch <span class="figure-caption_symbol">=</span> choroid; Co <span class="figure-caption_symbol">=</span> cornea; Ir <span class="figure-caption_symbol">=</span> iris; Le <span class="figure-caption_symbol">=</span> lens anterior capsule; Pa <span class="figure-caption_symbol">=</span> pars plicata; PC <span class="figure-caption_symbol">=</span> posterior chamber; Sc <span class="figure-caption_symbol">=</span> sclera; Zo <span class="figure-caption_symbol">=</span> zonular fibers. <span class="figure-source-note">(Courtesy of </span><span class="figure-source-note">Vi</span><span class="figure-source-note">kram&#160;S. Brar, MD.)</span></p>
				</div>
				<div id="_idContainer056" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-2" src="Operator_BCSC2019_S02_C17_p451_476_3aP-web-resources/image/fig_17_15.png" alt="" />
				</div>
			</div>
		</div>
		<div id="_idContainer058" class="Basic-Text-Frame">
			<table id="table009" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-55" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1">
							<p class="table-title"><span class="table-number">&#173;Table&#160;17-6</span> Recommendations for Ordering Imaging Studies in Ophthalmology</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-56">
						<td class="Basic-Table CellOverride-28">
							<p class="table-body">Decide &#173;whether a CT or MR scan is indicated. In most cases, MRI is superior to CT for neuro-&#173;ophthalmic indications. CT is superior to MRI for visualizing calcifications, bone, and acute hemorrhage and when an emergent scan is needed. CT is also used when the patient cannot undergo MRI.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-29">
							<p class="table-body">Decide &#173;whether contrast-&#173;material enhancement is needed. In most cases, contrast material should be ordered for all studies. Contrast enhancement may not be necessary in acute hemorrhage, thyroid ophthalmopathy, and trauma cases.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Localize the lesion clinically (“Where is the lesion?”), and then order a study tailored to the location (eg, head, orbit, neck). To obtain the correct study, take the time to fill out the radiographic order form personally with sufficient clinical details for the radiologist. Do not just order a “brain MRI” for &#173;every case.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Depending on the clinical indication, consider ordering special imaging sequences (eg, fat suppression for an orbital postcontrast study, fluid attenuation inversion recovery for white &#173;matter lesions, gradient echo for hemorrhage).</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Call the radiologist and tell him or her the differential diagnosis (“What is the lesion?”) and the location (“Where is the lesion?”).</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">If the imaging shows &#173;either no abnormality or an abnormality that does not match the clinical location, call the radiologist or, better yet, review the films directly with him or her. Ask the radiologist if the area of interest has been adequately imaged, if artifact might be obscuring the lesion, or if additional studies might show the lesion.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">If the clinical picture suggests a specific lesion or location and initial imaging is “normal,” consider repeating the imaging study with thinner sections and higher magnification of the area of interest, especially if the clinical signs and symptoms are progressive.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-36">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Recognize that the lack of an abnormality on imaging does not exclude pathology.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-6">
							<p class="table-source-note">CT <span class="table-source-note_symbol">=</span> computed tomography; MRI <span class="table-source-note_symbol">=</span> magnetic resonance imaging.</p>
							<p class="table-source-note">Modified with permission from Lee AG, Brazis PW, Garrity JA, White&#160;M. Imaging for neuro-&#173;ophthalmic and orbital disease. <span class="table-source-note_italic">Am J Ophthalmol.</span> 2004;138(5):855.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer059" class="Basic-Text-Frame">
			<table id="table010" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-57" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-59" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-60" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-61" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">&#173;Table&#160;17-7</span> Neuro-&#173;Ophthalmic Indications and Recommended Imaging Study</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Indication</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Imaging Study</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Contrast Material</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Comment</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-62">
						<td class="Basic-Table CellOverride-30">
							<p class="table-body">Optic nerve drusen</p>
						</td>
						<td class="Basic-Table CellOverride-30" />
						<td class="Basic-Table CellOverride-30" rowspan="2">
							<p class="table-body">CT scan of the orbit (may show calcification)</p>
							<p class="table-body">B-&#173;scan ultrasono&#173;graphy (axial)</p>
						</td>
						<td class="Basic-Table CellOverride-30" rowspan="2" />
						<td class="Basic-Table CellOverride-30" rowspan="2">
							<p class="table-body">Not necessary</p>
						</td>
						<td class="Basic-Table CellOverride-30" rowspan="2" />
						<td class="Basic-Table CellOverride-30" rowspan="2">
							<p class="table-body">Ultrasonography is less costly and more sensitive than a CT scan for drusen.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-53">
						<td class="Basic-Table CellOverride-31" />
						<td class="Basic-Table CellOverride-31" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-63">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Papilledema</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">MRI of the head <br />(with MRV)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Consider contrast MRV to exclude venous sinus thrombosis, especially in aty&#173;pi&#173;cal patients with idiopathic intracranial hypertension (IIH, formerly known as <span class="table-body_italic">pseudotumor cerebri</span>) and who are thin, male, or el&#173;derly.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32" />
						<td class="Basic-Table CellOverride-32" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-64">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Transient vision loss (amaurosis fugax)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRA or CTA of the neck for carotid stenosis or dissection</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Depends on clinical situation</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">An adjunctive carotid Doppler study or catheter angiography may be required.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-65">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Demyelination optic neuritis</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the head <br />and orbit</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Consider FLAIR to look for demyelinating white &#173;matter lesions; MRI has prognostic significance for the development of multiple sclerosis.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-66">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Inflammatory, infiltrative, or compressive optic neuropathy</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the head <br />and orbit</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Fat suppression &#173;will exclude intraorbital optic nerve enhancement; CT is superior in traumatic optic neuropathy for canal fractures.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-67">
						<td class="Basic-Table CellOverride-33">
							<p class="table-body">Junctional scotoma (ie, optic neuropathy in 1 eye and superotemporal visual field loss in fellow eye)</p>
						</td>
						<td class="Basic-Table CellOverride-33" />
						<td class="Basic-Table CellOverride-33">
							<p class="table-body">MRI of the head (attention to the sella)</p>
						</td>
						<td class="Basic-Table CellOverride-33" />
						<td class="Basic-Table CellOverride-33">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-33" />
						<td class="Basic-Table CellOverride-33" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-68">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Bitemporal hemianopia</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the head (attention to the chiasm and sella)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Consider CT of the sella if an emergent scan is needed (eg, pituitary or chiasmal apoplexy) or when imaging for calcification (eg, meningioma, craniopharyngioma, or aneurysm).</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-69">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Homonymous hemianopia</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">MRI of the head</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Retrochiasmal pathway. DWI may be useful with acute ischemic infarct. If structural imaging is negative and &#173;there is organic loss, consider functional imaging.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-34">
							<p class="table-column-head">Indication</p>
						</td>
						<td class="Basic-Table CellOverride-34" />
						<td class="Basic-Table CellOverride-34">
							<p class="table-column-head">Imaging Study</p>
						</td>
						<td class="Basic-Table CellOverride-34" />
						<td class="Basic-Table CellOverride-34">
							<p class="table-column-head">Contrast Material</p>
						</td>
						<td class="Basic-Table CellOverride-34" />
						<td class="Basic-Table CellOverride-34">
							<p class="table-column-head">Comment</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-68">
						<td class="Basic-Table CellOverride-35">
							<p class="table-body">Cortical vision loss or visual association cortex (eg, ce&#173;re&#173;bral achromatopsia, alexia, prosopagnosia, simultagnosia, optic ataxia, Balint syndrome)</p>
						</td>
						<td class="Basic-Table CellOverride-35" />
						<td class="Basic-Table CellOverride-35">
							<p class="table-body">MRI of the head</p>
						</td>
						<td class="Basic-Table CellOverride-35" />
						<td class="Basic-Table CellOverride-35">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-35" />
						<td class="Basic-Table CellOverride-35">
							<p class="table-body">Retrochiasmal pathway. DWI may be useful with acute ischemic infarct. If structural imaging is negative and &#173;there is organic loss, consider functional imaging (eg, PET, SPECT, MRS).</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Third, fourth, or sixth nerve palsy or cavernous sinus syndrome</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the head with attention to the skull base; isolated vasculopathic cranial neuropathies may not require initial imaging</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Rim calcification in aneurysm, calcification in tumors, and hyperostosis may be better seen <br />on CT.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Internuclear ophthalmoplegia (INO), supranuclear or nuclear gaze palsies, dorsal midbrain syndrome, skew deviation</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the head (brainstem)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Rule out demyelinating or other brainstem lesion; include a FLAIR sequence.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Nystagmus</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the brainstem</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Localize nystagmus.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-66">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hemifacial spasm</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the brainstem (with or without MRA)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Compression of the facial nerve root near its exit from the brainstem by adjacent artery, eg, anterior/posterior inferior cerebellar artery.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-64">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Horner syndrome: preganglionic</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI of the head and neck to the second thoracic vertebra (T2) in the chest with neck MRA</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Rule out lateral medullary infarct, apical lung neoplasm, carotid dissection, &#173;etc.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-70">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Horner syndrome: postganglionic</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">MRI of the head and neck to the level of the superior cervical ganglion (C4 level) with MRA of the neck</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Rule out carotid dissection; isolated postganglionic lesions are often benign.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-71">
						<td class="Basic-Table CellOverride-6" colspan="7">
							<p class="table-source-note">CT <span class="table-source-note_symbol">=</span> computed tomography; CTA <span class="table-source-note_symbol">=</span> CT angiography; DWI <span class="table-source-note_symbol">=</span> diffusion-&#173;weighted imaging; FLAIR <span class="table-source-note_symbol">=</span> fluid attenuation inversion recovery; MRA <span class="table-source-note_symbol">=</span> magnetic resonance angiography; MRI <span class="table-source-note_symbol">=</span> magnetic resonance &#173;imaging; MRS <span class="table-source-note_symbol">=</span> magnetic resonance spectroscopy; MRV <span class="table-source-note_symbol">=</span> magnetic resonance venography; PET <span class="table-source-note_symbol">=</span> positron emission tomography; SPECT <span class="table-source-note_symbol">=</span> single-&#173;photon emission computed tomography.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-72">
						<td class="Basic-Table CellOverride-36" colspan="7">
							<p class="table-source-note">Modified with permission from Lee AG, Brazis PW, Garrity JA, White&#160;M. Imaging for neuro-&#173;ophthalmic and orbital disease. <span class="table-source-note_italic">Am J Ophthalmol.</span> 2004;138(5):854.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer060" class="Basic-Text-Frame">
			<p class="figure-caption ParaOverride-22"><span class="CharOverride-4">(Continued)</span></p>
		</div>
		<div id="_idContainer061" class="_idGenObjectStyleOverride-1">
			<table id="table011" class="Basic-Table _idGenTablePara-1">
				<colgroup>
					<col class="_idGenTableRowColumn-57" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-59" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-60" />
					<col class="_idGenTableRowColumn-58" />
					<col class="_idGenTableRowColumn-61" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">Table 17-7</span> <span class="CharOverride-5">(continued)</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Indication</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Imaging Study</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Contrast Material</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Comment</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer062" class="Basic-Text-Frame">
			</div>
		</div>
		<div id="_idContainer063" class="_idGenObjectStyleOverride-1">
			<table id="table012" class="Basic-Table _idGenTablePara-1">
				<colgroup>
					<col class="_idGenTableRowColumn-55" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-37">
							<p class="table-title"><span class="table-number">Table 17-7</span> <span class="CharOverride-5">(continued)</span></p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer064" class="Basic-Text-Frame">
			<table id="table013" class="Basic-Table">
				<colgroup>
					<col class="_idGenTableRowColumn-73" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-52" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-74" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-75" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">&#173;Table&#160;17-8</span> Orbital Indications and Recommendations for Imaging</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Orbital Lesion</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Imaging Study</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Contrast Enhancement</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Comment</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-56">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Thyroid eye disease</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">CT or MRI of the orbit</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Iodinated contrast medium may interfere with evaluation and treatment of systemic thyroid disease</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Bone anatomy is better seen on a CT scan, especially if orbital decompression is being considered.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Orbital cellulitis and orbital disease secondary to sinus disease (eg, &#173;silent sinus syndrome, sinusitis)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">CT of the orbit and sinuses</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Depends on clinical situation</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">MRI may be a useful adjunct to a CT scan, especially if concomitant cavernous sinus thrombosis is pre&#173;sent.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Nonspecific orbital inflammation</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">CT or MRI of the orbit (with fat suppression)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Beware of fat suppression artifact.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-64">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Orbital tumor (eg, proptosis or enophthalmos, gaze-&#173;evoked vision loss)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">CT or MRI of the orbit</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Include head imaging if lesion could extend intracranially (eg, optic nerve sheath meningioma); CT scan may be superior if looking for hyperostosis or calcification (eg, sheath meningioma).</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-21">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Orbital trauma (eg, fracture, subperiosteal hematoma, orbital foreign body, orbital emphysema)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">CT scan of the orbit with axial and direct coronal imaging</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Not generally necessary</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">CT is superior for visualizing a fracture or bone fragment; MRI may be superior for optic nerve sheath hemorrhage.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-67">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Carotid cavernous sinus or dural fistula (eg, orbital bruit, arterialization of conjunctival and episcleral vessels, glaucoma)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">CT or MRI of the head and orbit (with contrast-&#173;enhanced MRA)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Yes</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">CT or MRI may show an enlarged superior ophthalmic vein and may require a catheter angiogram for final diagnosis and therapy. Color flow Doppler studies may be useful for detecting reversal of orbital venous flow.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-76">
						<td class="Basic-Table CellOverride-6" colspan="7">
							<p class="table-source-note">CT <span class="table-source-note_symbol">=</span> computed tomography; MRA <span class="table-source-note_symbol">=</span> magnetic resonance angiography; MRI <span class="table-source-note_symbol">=</span> magnetic resonance imaging.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-36" colspan="7">
							<p class="table-source-note">Modified with permission from Lee AG, Brazis PW, Garrity JA, White&#160;M. Imaging for neuro-&#173;ophthalmic and orbital disease. <span class="table-source-note_italic">Am J Ophthalmol.</span> 2004;138(5):857.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
	</body>
</html>
